KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to $1.6 million.

  • Petmed Express' Receivables - Net fell 3098.72% to $1.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 million, marking a year-over-year decrease of 3098.72%. This contributed to the annual value of $2.3 million for FY2025, which is 2942.43% down from last year.
  • Per Petmed Express' latest filing, its Receivables - Net stood at $1.6 million for Q4 2025, which was down 3098.72% from $2.0 million recorded in Q3 2025.
  • Petmed Express' Receivables - Net's 5-year high stood at $3.3 million during Q1 2024, with a 5-year trough of $1.3 million in Q4 2021.
  • For the 5-year period, Petmed Express' Receivables - Net averaged around $2.0 million, with its median value being $1.9 million (2022).
  • Its Receivables - Net has fluctuated over the past 5 years, first crashed by 3268.28% in 2021, then soared by 8867.82% in 2024.
  • Over the past 5 years, Petmed Express' Receivables - Net (Quarter) stood at $1.3 million in 2021, then soared by 53.43% to $1.9 million in 2022, then decreased by 0.72% to $1.9 million in 2023, then grew by 17.05% to $2.3 million in 2024, then crashed by 30.99% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q4 2025, $2.0 million for Q3 2025, and $1.6 million during Q2 2025.